Therapeutic effect and safety of oral musk Baoxin pill in patients with stable angina pectoris of coro-nary heart disease / 心血管康复医学杂志
Chinese Journal of cardiovascular Rehabilitation Medicine
;
(6): 684-687, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-733605
ABSTRACT
Objective:
To explore therapeutic effect and safety of oral musk Baoxin pill in patients with stable angina pectoris (SAP) of coronary heart disease (CHD).Methods:
A total of 158 SAP patients of CHD treated in our hos-pital were selected,and were randomly divided into routine treatment group (n=79) and musk Baoxin pill group (n=79,received musk Baoxin pill based on routine treatment ),both groups were treated for eight weeks.Therapeutic effect and safety were compared between two groups.Results:
After treatment,there was no significant difference in total effective rate of ECG improvement between two groups,P=0.475.Compared with routine treatment group after treatment,there were significant reductions in onset times of angina pectoris [(1.68 ± 0.43) times/d vs.(1.12 ± 0.37) times/d] and nitroglycerin consumption [(1.65 ± 0.87)/d vs.(1.08 ± 0.47)/d],and significant rise in to-tal effective rate of angina pectoris improvement (81.01% vs.96.20%) in musk Baoxin pill group,P=0.001 all.No obvious adverse reactions occurred in two groups.Conclusion:
Oral musk Baoxin pill based on routine treatment can significantly relieve angina pectoris symptoms and the safety is good in patients with stable angina pectoris of coronary heart disease.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of cardiovascular Rehabilitation Medicine
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS